Ruben Danielyan | Public Health | Best Researcher Award

Published on by Health Scientists

Mr. Ruben Danielyan | Public Health | Best Researcher Award

Medical Entomologist | National Center for Disease Control and Prevention | Armenia

Dr. Ruben Danielyan is a veterinary scientist and public health researcher specializing in zoonotic and vector-borne diseases, with a strong focus on medical zoology, entomology, parasitology, and disease ecology. His work integrates field and laboratory investigations with advanced geographic information systems and spatial epidemiology to analyze hosts, vectors, and natural disease foci. He has authored numerous peer-reviewed publications in international journals addressing tularemia, plague, Crimean–Congo hemorrhagic fever, echinococcosis, and other emerging infections, with research that is widely cited within the global scientific community. Dr. Danielyan has collaborated extensively with international research networks through multidisciplinary One Health projects across the South Caucasus and neighboring regions. His contributions support evidence-based surveillance, risk mapping, and climate-sensitive disease prediction, providing significant societal impact by strengthening public health preparedness, biodiversity-informed disease control, and regional biosecurity strategies. He has 2 citations from 5 documents with an h-index of 1.

Citation Metrics (Scopus)

8
6
4
2
0

Citations

2

Documents

5

h-index

1

Citations

Documents

h-index

View Scopus Profile View Orcid Profile

Featured Publications

Yanisa Pumsutas | Public Health | Research Excellence Award

Published on by Health Scientists

Ms. Yanisa Pumsutas | Public Health | Research Excellence Award

Research assistant | International Health Policy Program | Thailand

Miss Yanisa Pumsutas is a Thai nutrition scientist and registered dietitian serving as a Research Assistant at the Health Promotion Policy Research Center under the International Health Policy Foundation in Thailand, with a strong academic foundation in nutrition and dietetics from Chulalongkorn University and advanced postgraduate training at Mahidol University. Her professional expertise spans public health nutrition, health promotion policy, noncommunicable diseases, metabolic disorders, eating behavior, and clinical nutrition counseling. She is a licensed dietitian recognized by the Thai Dietetics Council and has held key clinical roles at leading tertiary hospitals including Bumrungrad International Hospital and Phramongkutklao Hospital, where she contributed extensively to patient care, multidisciplinary nutrition management, and professional training. Her research portfolio includes multiple peer reviewed publications as both first author and co author in high impact international journals covering obesogenic environments, refugee health access, sleep and physical activity in older adults, metabolic liver disease, work related obesity, renal nutrition, and cancer cachexia. She has also been actively involved in randomized clinical trials, systematic and scoping reviews, and community based nutrition research. Her work is widely cited and demonstrates strong interdisciplinary collaboration with national and international public health, medical, and policy research teams. In addition to research, she has made significant contributions to academic service through professional nutrition societies, where she has supported scientific conferences, delivered specialized training workshops, and contributed to policy and practice dissemination. Her work has generated meaningful societal impact by supporting evidence based nutrition policy, strengthening clinical nutrition services, improving health literacy, and advancing equitable access to healthcare for vulnerable populations, reflecting her strong commitment to translating nutritional science into sustainable public health outcomes. She has 27 citations from 5 documents with an h-index of 2.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Thambamroong, T., Seetalarom, K., Saichaemchan, S., Pumsutas, Y., & colleagues. (2022). Efficacy of curcumin on treating cancer anorexia-cachexia syndrome in locally or advanced head and neck cancer: A double-blind, placebo-controlled randomised phase IIa trial.

2. Chirapongsathorn, S., Rintaravitoon, W., Tangjaturonrasme, B., & colleagues. (2025). Effect of a ketogenic diet on metabolic dysfunction-associated steatotic liver disease (MASLD) progression: A randomized controlled trial.

3. Chirapongsathorn, S., Rintaravitoon, W., Tangjaturonrasme, B., & colleagues. (2023). Effect of a ketogenic diet on nonalcoholic fatty liver disease (NAFLD) progression: A randomized controlled trial.

4. Thambamroong, T., Seetalarom, K., Saichaemchan, S., Pumsutas, Y., & colleagues. (2022). Efficacy of curcumin on treating cancer anorexia-cachexia syndrome in locally or advanced head and neck cancer: A double-blind, placebo-controlled randomised trial.

5. Satirapoj, B., Varothai, N., Boonyagarn, N., Pumsutas, Y., Chotsriluecha, S., & colleagues. (2020). Effect of renal specific oral nutrition (ONCE Renal) on dietary intake and serum electrolytes in chronic kidney disease.

Mai Kadry | Global Health | Editorial Board Member

Published on by Health Scientists

Assist. Prof. Dr. Mai Kadry | Global Health | Editorial Board Member 

Research Scientist | National Research Center | Egypt

Mai O. Kadry is a distinguished researcher at the National Research Centre in Giza, Egypt, recognized for her multidisciplinary contributions across metabolomics, molecular oncology, nanomedicine, toxicology, and women’s health research. Her scientific portfolio reflects a sustained commitment to unraveling the biochemical and molecular mechanisms underpinning complex diseases, with a particular focus on metabolic disorders, cancer progression, reproductive toxicology, and innovative therapeutic strategies. Through a substantial body of peer-reviewed publications, she has advanced understanding of how metabolic signatures, genomic interactions, and molecular signaling pathways can be leveraged to improve disease diagnosis, treatment response, and therapeutic safety. Her work frequently integrates serum metabolomics, network pharmacology, lipidomics, nanostructure-based drug delivery, and experimental validation models, enabling a comprehensive systems-level view of disease processes. She has collaborated extensively with national and international scientists, contributing to multidisciplinary studies on phytotherapeutics for endocrine disorders, nanoscale interventions to mitigate chemotherapeutic toxicity, and molecular crosstalk driving drug resistance in cancer cells. Her authorship and citation footprint reflect broad scholarly engagement, while her active participation in multi-institutional teams has supported knowledge exchange and capacity building within the biomedical research community. Kadry’s investigations into natural product therapeutics, oxidative brain injury mechanisms, autophagy regulation, and emerging RNA-based biomarkers contribute to public health and precision medicine, offering insights with potential translational relevance to women’s health, oncology, toxicology, and environmental exposure science. Collectively, her work demonstrates a strong commitment to scientific innovation, interdisciplinary integration, and the societal importance of developing safer, more effective therapeutic approaches that align with global health priorities. She has 462 citations from 50 documents with an h-index of 12.

Profiles: Scopus | ORCID

Featured Publications

1. Kadry, M., Author, A. A., Author, B. B., … (2025). Exploring the therapeutic potential of marjoram (Origanum majorana L.) in polycystic ovary syndrome: Insights from serum metabolomics, network pharmacology and experimental validation.

2. Kadry, M., & Author, A. A. (2025). Novel insights into SNORD-78 and miR-122-5P: The predicted diagnostic indexes of lung cancer—Drug-loaded liposome formulations competing methylcholanthrene-induced lung cancer.

3. Kadry, M., Author, A. A., Author, B. B., Author, C. C., & Author, D. D. (2025). Oxidative brain injury ascending from DMBA: Metabolomics and BRAF3/FKBR/A2m molecular signaling crosstalk.

4. Kadry, M., Author, A. A., Author, B. B., … (2025). Metabolomics integrated genomics approach: Understanding multidrug resistance phenotype in MCF-7 breast cancer cells exposed to doxorubicin and ABCA1/EGFR/PI3K/PTEN crosstalk.

5. Kadry, M., Author, A. A., & Author, B. B. (2025). Titanium nanostructure mitigating doxorubicin-induced testicular toxicity in rats via regulating major autophagy signaling pathways.